Charitable trust registration requires a specified-violation notice; settled cash deposits and related-party payments did not justify cancellation or ...
External development charges trigger TDS under section 194C, while disputed administrative payments require factual verification and fresh adjudicatio...
Section 270AA penalty immunity requires identified statutory defaults and a hearing before rejection; reassessment disclosure may constitute under-rep...
Section 80JJAA employee-cost deduction allowed for deployed staff but barred against transfer-pricing income enhancement, with pricing issues remanded...
Transfer-pricing methodology protects commercially genuine associated-enterprise payments, while pre-2016 secondary adjustments and related notional i...
Negative liens over operating assets can constitute international transactions requiring arm's-length pricing reflecting restricted borrowing and expa...
Cross-examination rights in Customs Broker revocation inquiries require witness examination; procedural denial may be cured through fresh adjudication...
The ITAT ruled against the transfer pricing adjustment for AMP expenses, finding tax authorities failed to demonstrate that such expenses benefited the foreign AE's brand. The Tribunal held that AMP expenditure quantum alone cannot establish benefit to AEs, as brands are customer-centric rather than product-centric. Regarding royalty payments, the ITAT found the TPO's rejection of comparable agreements unjustified. Issues concerning management service fees, interest on outstanding receivables, and payments to 'Dart' were remanded to the AO/TPO for fresh determination in accordance with precedents from earlier assessment years and relevant case law, including Kusum Healthcare. All grounds were sustained either substantively or for statistical purposes.
The ITAT ruled against the transfer pricing adjustment for AMP expenses, finding tax authorities failed to demonstrate that such expenses benefited the foreign AE's brand. The Tribunal held that AMP expenditure quantum alone cannot establish benefit to AEs, as brands are customer-centric rather than product-centric. Regarding royalty payments, the ITAT found the TPO's rejection of comparable agreements unjustified. Issues concerning management service fees, interest on outstanding receivables, and payments to 'Dart' were remanded to the AO/TPO for fresh determination in accordance with precedents from earlier assessment years and relevant case law, including Kusum Healthcare. All grounds were sustained either substantively or for statistical purposes.
Note: It is a system-generated summary and is for quick reference only.